| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP Chief Financial Officer
1 company
Vairavan Latha is a SVP Chief Financial Officer at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | ARQT Arcutis Biotherapeutics, Inc. | SVP Chief Financial Officer | Sell | 435 | $21.05 | $9,156.75 | -0.5% | - | - | |
| Nov 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SVP Chief Financial Officer | Sell | 88 | $24.72 | $2,175.23 | -0.1% | +3.3% | - | |
| Aug 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SVP Chief Financial Officer | Sell | 89 | $14.33 | $1,275.07 | -0.1% | +70.5% | - |